Industry sponsor intelligence
Lead-sponsor view of Bausch Health Americas, Inc.'s indexed peptide studies, development phases, active programs, completed work and recent registry changes.
Pipeline overview
Velocity
Study start year · indexed snapshot
Development
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Plecanatide → | 13 | 0 | 6 | 7 | 0 | 1 |
Active peptide trials
Bausch Health Americas, Inc. · Functional Constipation (FC)
Phase 2
Active, not recruiting
180
2026-07
Completed trials
Bausch Health Americas, Inc. · Irritable Bowel Syndrome With Constipation
Phase 2
Completed
218
2025-12
Bausch Health Americas, Inc. · Irritable Bowel Syndrome
Phase 3
Completed
2,272
2020-08
Bausch Health Americas, Inc. · Chronic Idiopathic Constipation
Phase 2
Completed
84
2020-01
Bausch Health Americas, Inc. · Chronic Idiopathic Constipation
Phase 3
Completed
1,394
2019-12
Bausch Health Americas, Inc. · Chronic Idiopathic Constipation
Not applicable
Completed
7
2019-11
Bausch Health Americas, Inc. · Chronic Idiopathic Constipation
Phase 2
Completed
124
2019-10
Bausch Health Americas, Inc. · Chronic Idiopathic Constipation
Phase 3
Completed
2,370
2019-07
Bausch Health Americas, Inc. · Irritable Bowel Syndrome Characterized by Constipation
Phase 3
Completed
1,054
2019-06
Bausch Health Americas, Inc. · Irritable Bowel Syndrome Characterized by Constipation
Phase 3
Completed
1,135
2019-06
Bausch Health Americas, Inc. · Chronic Idiopathic Constipation
Phase 2 / Phase 3
Completed
951
2019-05
Search sponsor records
This page groups studies where Bausch Health Americas, Inc. is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
13 matching studies
Last registry update first
Recent updates